Key Record Dates
ClinicalTrials.gov Identifier: | NCT03720626 |
---|---|
Brief Title: | MAP to Provide Access to Crizanlizumab, for Sickle Cell Disease Patients |
First Submitted : | October 24, 2018 |
First Submitted that Met QC Criteria : | October 24, 2018 |
First Posted : | October 25, 2018 |
Last Update Submitted that Met QC Criteria : | December 22, 2022 |
Last Update Posted : | December 23, 2022 |